Alpha Lipoic Acid (ALA) vs TUDCA (Tauroursodeoxycholic Acid)

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

✅ Stacking Partners — These compounds are commonly used together and may have synergistic effects.
Alpha Lipoic Acid (ALA)TUDCA (Tauroursodeoxycholic Acid)
CategorySupplementsSupplements
Standard Dose300-600mg R-ALA daily250-500mg daily
TimingOn empty stomach, 30-60 min before meals. Split doses for higher amounts.With meals for liver support. Some protocols recommend before meals to prime bile flow.
Cycle Durationongoing or cycle 12 weeks on, 4 weeks offCycle 4-8 weeks for liver support; ongoing at low dose for chronic liver conditions under supervision
Evidence Levelstrong_humanModerate-Strong

Mechanism

ALA is a dithiol compound that functions as a cofactor for mitochondrial alpha-keto acid dehydrogenases (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase). Both ALA and its reduced form DHLA are potent antioxidants capable of regenerating other antioxidants including vitamin C, vitamin E, and glutathione. ALA activates AMPK, improving glucose uptake via GLUT4 translocation, and modulates NF-kB-mediated inflammatory signaling. It chelates redox-active metals (Fe2+, Cu2+).

Standard Dosing

300-600mg R-ALA daily

Timing

On empty stomach, 30-60 min before meals. Split doses for higher amounts.

Cycle Duration

ongoing or cycle 12 weeks on, 4 weeks off

Side Effects

  • GI upset/nausea
  • Skin rash
  • Hypoglycemia symptoms
  • Body odor changes

Contraindications

  • Thiamine (B1) deficiency (ALA increases thiamine demand)
  • Hypoglycemia-prone individuals without monitoring
  • Autoimmune thyroid conditions (monitor thyroid function)

Best Stacking Partners

NACCoQ10Acetyl-L-CarnitineBiotinChromium

Mechanism

TUDCA is a water-soluble bile acid conjugate (taurine + ursodeoxycholic acid) with potent hepatoprotective and cytoprotective properties. It inhibits the mitochondrial pathway of apoptosis by preventing BAX translocation to mitochondria and cytochrome c release. TUDCA reduces endoplasmic reticulum (ER) stress by acting as a chemical chaperone, assisting protein folding and reducing the unfolded protein response (UPR). It protects hepatocytes by stabilizing cell membranes, displacing toxic hydrophobic bile acids (chenodeoxycholic, lithocholic) from biliary epithelium, and promoting choleresis (bile flow). Additionally, it has neuroprotective effects via reduction of ER stress in neurons and modulation of the TGR5 bile acid receptor.

Standard Dosing

250-500mg daily

Timing

With meals for liver support. Some protocols recommend before meals to prime bile flow.

Cycle Duration

Cycle 4-8 weeks for liver support; ongoing at low dose for chronic liver conditions under supervision

Side Effects

  • Diarrhea (dose-dependent)
  • GI discomfort
  • Flatulence
  • Rare: calcification of gallstones

Contraindications

  • Complete biliary obstruction (cannot reach bile ducts if obstruction is complete)
  • Calcified gallstones (UDCA/TUDCA dissolve cholesterol stones, not calcified)
  • Acute cholangitis
  • Complete biliary obstruction
  • Gallstones (may mobilize stones)

Best Stacking Partners

Milk Thistle (Silymarin)NACAlpha Lipoic AcidArtichoke Extract

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →